Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB
Thomas Sonnweber(Innsbruck Medical University), Günter Weiß(Innsbruck Medical University), Victor J. Wroblewski(Eli Lilly (United States)), Manfred Nairz(Innsbruck Medical University), Anna‐Maria Mitterstiller(Innsbruck Medical University), David Haschka(Innsbruck Medical University), Egon Demetz(Innsbruck Medical University), Susanne Trübsbach(Innsbruck Medical University), Andrea Schroll(Innsbruck Medical University), Antonello Pietrangelo(University of Modena and Reggio Emilia), Axel Kleinsasser(Innsbruck Medical University), Igor Theurl(Innsbruck Medical University), David Nachbaur(Innsbruck Medical University), Martina U. Muckenthaler(Heidelberg University), Derrick R. Witcher(Eli Lilly (United States)), Martin Burtscher(Universität Innsbruck), Chiara Vecchi(Hesperia Hospital), Markus Seifert(Innsbruck Medical University), Katarzyna Mleczko‐Sanecka(International Institute of Molecular and Cell Biology)
Cited by 147
Related Papers
Macrophage defense mechanisms against intracellular bacteria
|Immunological Reviews|2015|975
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
|Blood|2010|485
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
|Kidney International|2016|474
<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
|Journal of Clinical Oncology|2011|450
Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases
|International Journal of Molecular Sciences|2018|438